Abstract: Zymomonas expressing xylose isomerase from A. missouriensis was found to have improved xylose utilization, growth, and ethanol production when grown in media containing xylose. Xylose isomerases related to that of A. missouriensis were identified structurally through molecular phylogenetic and Profile Hidden Markov Model analyses, providing xylose isomerases that may be used to improve xylose utilization.
Type:
Grant
Filed:
June 16, 2011
Date of Patent:
January 7, 2014
Assignee:
E I du Pont de Nemours and Company
Inventors:
Robel Y. Kahsay, Min Qi, Luan Tao, Paul V. Viitanen, Jianjun Yang
Abstract: The invention provides, biologically active spinosyns, hybrid spinosyn polyketide synthases capable of functioning in Saccharopolyspora spinosa to produce the spinosyns, and methods of controlling insects using the spinosyns.
Type:
Grant
Filed:
March 28, 2011
Date of Patent:
January 7, 2014
Assignee:
Dow AgroSciences, LLC.
Inventors:
Lesley S. Burns, Paul R. Graupner, Paul Lewer, Christine J. Martin, William A. Vousden, Clive Waldron, Barrie Wilkinson
Abstract: Modified DNA polymerases have an affinity for DNA such that the polymerase has an ability to incorporate one or more nucleotides into a plurality of separate DNA templates in each reaction cycle. The polymerases are capable of forming an increased number of productive polymerase-DNA complexes in each reaction cycle. The modified polymerases may be used in a number of DNA sequencing applications, especially in the context of clustered arrays.
Type:
Grant
Filed:
May 10, 2006
Date of Patent:
January 7, 2014
Assignee:
Illumina, Inc.
Inventors:
Tobias William Barr Ost, Geoffrey Paul Smith, Shankar Balasubramanian, Roberto Rigatti, Raquel Maria Sanches
Abstract: The present invention relates to nucleic acids and nucleic acid fragments encoding amino acid sequences for flavonoid biosynthetic enzymes in plants, and the use thereof for the modification of flavonoid biosynthesis in plants. More particularly, the flavonoid biosynthetic enzyme is selected from the group consisting of chalcone isomerase (CHI), chalcone synthase (CHS), chalcone reductase (CHR), dihydroflavonol 4-reductase (DFR), leucoanthocyanidin reductase (LCR), flavonoid 3?, 5? hydrolase (F3?5?H), flavanone 3-hydroxylase (F3H), flavonoid 3?-hydroxylase (F3?H), phenylalanine ammonia-olyase (PAL) and vestitone reductase (VR), and functionally active fragments and variants thereof.
Type:
Application
Filed:
September 13, 2013
Publication date:
January 2, 2014
Applicants:
AgResearch Limited, Agriculture Victoria Services Pty Ltd
Inventors:
German Spangenberg, Timothy Ivor Sawbridge, Eng-Kok Ong, Michael Emmerling
Abstract: Disclosed is a thermostable tannase derived from a microorganism. Specifically disclosed is a thermostable tannase derived from Aspergillus awamori or Aspergillus niger. A preferred embodiment of the tannase has the following chemoenzymatic properties: (1) activity: to act on a depside bond to thereby cause hydrolysis; (2) molecular weight: about 230,000 Da (as measured by gel filtration); and (3) thermal stability: stable at a temperature up to 65° C. (pH 5.0, 30 min.
Abstract: The present invention provides antibiofilm composition comprising two or more agents selected from the group consisting of DispersinB™, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K for preventing growth and proliferation of biofilm-embedded microorganisms in wound care, oral care, and disease-related infections and methods of treatment in mammals. The invention further provides methods for preparing medical devices, and wound care devices using an antibiofilm composition comprising two or more antimicrobial agents selected from the group consisting of DispersinB™, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K.
Abstract: A method for producing butanol through microbial fermentation, in which the butanol product is removed during the fermentation by extraction into a water-immiscible organic extractant in the presence of at least one electrolyte at a concentration at least sufficient to increase the butanol partition coefficient relative to that in the presence of the salt concentration of the basal fermentation medium, is provided. The electrolyte may comprise a salt which dissociates in the fermentation medium, or in the aqueous phase of a biphasic fermentation medium, to form free ions. Also provided is a method and composition for recovering butanol from a fermentation medium.
Abstract: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.
Type:
Grant
Filed:
December 19, 2011
Date of Patent:
December 31, 2013
Assignee:
Codexis, Inc.
Inventors:
Jack Liang, Birthe Borup, Vesna Mitchell, Emily Mundorff, James Lalonde, Gjalt Huisman
Abstract: A Clostridium histolyticum collagenase ColH (Glu451Asp) melts adipose tissue when injected into selected regions of the body. This protein product melts fat pads effectively in fat rat experiments, with very little side effects. Very little hemorrhage was observed. We also invent a new version of ColH mutant by linking a peptide motif CKGGRAKDC-G (varying from 2 to 6 Gs) (SEQ ID NO: 2) in front of ColH (Glu451Asp) (called topical ColH-FM), which can target to white fat vasculature. By combining with novel transdermal technology (such as Hydroxysome technology), we develop a topical protein cream that can melt fat. This product can be used as cellulite cream and for chemical liposuction. This topical ColH-FM can also be injected into adipose tissue as a replacement for liposuction or as an adjunct method with liposuction. Since raise scar is formed by overgrowth of collagen, our topical ColH-FM cream is shown to have application in scar reduction.
Type:
Grant
Filed:
February 13, 2008
Date of Patent:
December 31, 2013
Assignee:
Yolare Pharmaceuticals, LLC
Inventors:
Lan Huang, Yong Cang, Renato (Rene) Jose
Abstract: The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.
Type:
Application
Filed:
February 15, 2013
Publication date:
December 26, 2013
Applicants:
PANGU BIOPHARMA LIMITED, ATYR PHARMA, INC.
Inventors:
Kyle P. Chiang, Elisabeth Gardiner, Ching-Fun Lau, Wing-Sze Lo, Jeffrey Greve, Melissa Ashlock, John D. Mendlein
Abstract: A biomarker and a method for evaluating a risk for Parkinson's disease are disclosed. The method comprises: obtaining a sample from a tester, analyzing the polymorphic biomarker of the sample, wherein the biomarker is substrate-specifying subunit of SCF E3 ubiquitin ligase complex-FBXO7 gene; and when the cDNA sequence in position 155 of the biomarker is G or the amino acid sequence in position 52 of the biomarker is cysteine, it represents that the tester has a lower risk for Parkinson's disease.
Abstract: The invention provides a high resolution three-dimensional structure of cycloheximide, either alone or in association with a large ribosomal subunit. The invention provides methods for designing and/or identifying cycloheximide analogs and derivatives that bind and/or modulate the protein biosynthetic activity of the ribosome.
Abstract: Increasing tolerance to butanol in yeast has been accomplished by decreasing activity of Pdr5p encoded by an endogenous PDR5 gene. A deletion mutation of the PDR5 gene led to improved growth yield in the presence of butanol. Yeast cells with reduced Pdr5p activity, or other multidrug resistance ATP-binding cassette transporter protein activity encoded by CDR1 or BFR1, and a butanol biosynthetic pathway may be used for improved butanol production.
Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
Type:
Grant
Filed:
August 28, 2012
Date of Patent:
December 24, 2013
Assignees:
Novozymes, Inc, Novozymes A/S
Inventors:
Soren Flensted Lassen, Paul Harris, Elena Vlasenko, Kristian Krogh
Abstract: Methods are provided for recovery and formulation of insoluble enzymes from a microbial fermentation broth, without removal of microbial cells or cell debris. Granular and liquid formulations comprising insoluble enzymes are also provided.
Type:
Application
Filed:
June 10, 2013
Publication date:
December 19, 2013
Inventors:
Michael BODO, Robert I. CHRISTENSEN, Rajdeep S. DHALIWAL, Meng H. HENG
Abstract: The present invention aims to provide methods to detect cognitive impairment including mild cognitive impairment and Alzheimer disease by using a protein or its partial peptide that differs in presence or absence, or in quantity between non-cognitive impairment and patients with cognitive impairment and further aims to present biomarkers comprising said protein and said partial peptide to be used to detect cognitive impairment including Alzheimer disease or mild cognitive impairment. Specifically, a biomarker for diagnosis of psychiatry disease or cognitive impairment comprising protein fragment or peptide of not less than 5 amino acid residues arising from at least one protein or peptide selected from the group of proteins consisting of amino acid sequence expressed by SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, and 25 and selected from the group of partial peptide in these proteins consisting of amino acid sequence expressed by SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, and 27.
Abstract: The present invention relates to polynucleotides from Ostreococcus lucimarinus which code for desaturases and elongases and which can be employed for the recombinant production of polyunsaturated fatty acids. The invention furthermore relates to vectors, host cells and transgenic nonhuman organisms which comprise the polynucleotides, and to the polypeptides encoded by the polynucleotides. Finally, the invention also relates to production processes for the polyunsaturated fatty acids and for oil, lipid and fatty acid compositions.
Abstract: New mannose-6-phasphate isomerase, mutant enzyme thereof, and a method of producing L-ribose using the enzyme are provided, and more specifically, mannose-6-phosphate isomerase, mutant enzyme thereof, recombinant expression vectors including relevant genes, microorganisms transformed with the vectors, a method of producing mannose-6-phosphate isomerase or mutant thereof in bulk using them, and a high yield method of producing L-ribose using the mannose-6-isomerase or the mutant thereof, are provided.
Type:
Grant
Filed:
October 22, 2010
Date of Patent:
December 17, 2013
Assignee:
Konkuk University Industrial Cooperation Corp.
Abstract: The present invention relates to a modified Family 5 cellulase comprising a substitution of an amino acid at position 363 with a non-native alanine, serine or threonine, the position determined from alignment of the modified Family 5 cellulase with amino acids 71-397 of a Trichoderma reesei Cel5A amino acid sequence as set forth in SEQ ID NO:1 and enzyme mixtures comprising same. Additionally provided is a genetic construct comprising a nucleic acid sequence encoding the modified Family 5 cellulase and a genetically modified microbe comprising the genetic construct. The invention also provides a process for producing the modified Family 5 cellulase.
Type:
Grant
Filed:
March 11, 2011
Date of Patent:
December 17, 2013
Assignee:
Novozymes A/S
Inventors:
Nabil Masri, Patrick St-Pierre, Sandra Mortimer, Christopher M. D. Hill
Abstract: Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.
Type:
Application
Filed:
October 6, 2011
Publication date:
December 12, 2013
Inventors:
Leslie Ann Greene, Kyle P. Chiang, Fei Hong, Alain Philippe Vasserot, Wing-Sze Lo, Jeffry D. Watkins, Cheryl L. Quinn, John D. Mendlein
Abstract: At least at least one embodiment of the present invention relates to a method for using a high pressure-resistant enzyme in a high pressure condition; a method for promoting the activity of the high pressure-resistant enzyme by means of a high pressure treatment; a composition, which contains the high pressure-resistant enzyme, for decomposing proteins under a high pressure condition; a composition, which contains the composition for decomposing proteins, for preparing natural flavoring substances; a container for high pressure treatment, which contains the composition for decomposing proteins; and a method for measuring the activity of the high pressure-resistant enzyme, which comprises a step of decomposing an azocasein solution serving as a substrate by using the high pressure-resistant enzyme treated under a high pressure condition.
Type:
Application
Filed:
February 20, 2012
Publication date:
December 12, 2013
Applicant:
KOREA FOOD RESEARCH INSTITUTE
Inventors:
Nam-Soo Kim, Chong-Tai Kim, Yong-Jin Cho, Chul-Jin Kim, Jin-Soo Maeng, Soo-Jin Kwon
Abstract: The present invention relates to a polypeptide (BIG1) and variants thereof capable of enhancing the rate of cell-division of a microorganism or plant cell, as well as nucleic acid molecules encoding said polypeptides, vectors comprising said nucleic acid molecules and host cells transformed or transfected with said vectors and expressing said polypeptides. The BIG1 polypeptide which has been identified in the marine centric diatom Thalassiosira pseudonana, variants thereof and nucleic acids encoding these may be used in methods of enhancing the rate of cell-division of microorganisms, plant cells or plants which produce useful sub stances or exhibit useful properties, to increase the yield thereof.
Type:
Application
Filed:
February 10, 2012
Publication date:
December 12, 2013
Applicants:
University of Washington through its Center for Commercialization, University of East Anglia
Abstract: The present invention relates to polypeptides having cellobiohydrolase I activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
Type:
Grant
Filed:
May 30, 2012
Date of Patent:
December 10, 2013
Assignee:
Novozymes A/S
Inventors:
Lene Lange, Wenping Wu, Dominique Aubert, Sara Landvik, Kirk Matthew Schnorr, Ib Groth Clausen
Abstract: The present invention relates to methods and compositions for improving the productivity of recombinant vitamin K dependent protein expression in host cells.
Type:
Grant
Filed:
November 4, 2009
Date of Patent:
December 10, 2013
Assignee:
The University of North Carolina at Chapel Hill
Abstract: The present invention relates to novel xylose-fermenting yeast strains (for example, yeast of the genus Saccharomyces, e.g., S. cerevisiae) with an enhanced ability to ferment the xylose (and/or another pentose sugar) present in a lignocellulosic hydrolysate to a fermentation product(s) (for example, an alcohol (e.g., ethanol) or a sugar alcohol (e.g., xylitol)).
Type:
Grant
Filed:
December 30, 2010
Date of Patent:
December 10, 2013
Assignee:
Iogen Energy Corporation
Inventors:
Jennifer Donaldson, Jan-Maarten A. Geertman, Glenn D. Munkvold, Gary Pigeau, Philippe J. Dufresne, Loreta Gudynaite-Savitch
Abstract: The present invention relates to polypeptides having cellobiohydrolase I activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
Type:
Grant
Filed:
November 20, 2012
Date of Patent:
December 10, 2013
Assignee:
Novozymes A/S
Inventors:
Lene Lange, Wenping Wu, Dominique Aubert, Sara Landvik, Kirk Matthew Schnorr, Ib Groth Clausen
Abstract: The present invention relates to compositions and methods for stable transformation of green microalgae and for production of transgenic green microalgae and/or cyanobacteria that produce extremophile enzymes as co-products during the growth of the green microalgae and/or cyanobacteria for lipid biofuel production. Thus, the present invention provides nucleic acid constructs and methods of transformation useful in the production of stably transformed green microalgae and/or cyanobacteria expressing extremophile enzymes in combination with lipid production for biofuel.
Type:
Application
Filed:
February 3, 2012
Publication date:
December 5, 2013
Applicant:
North Carolina State University
Inventors:
Amy Michele Grunden, Heike Inge Ada Sederoff
Abstract: A homogeneously-structured catalyst/enzyme composite structure formed by electrophoresis deposition (EPD) method. Catalyst and enzyme are simultaneously deposited onto the electrode surface by the EPD method, so as to form a film of catalyst/enzyme composite thereon. The film of catalyst/enzyme composite includes enzyme for catalyzing the biochemical reaction, and catalyst for increasing the rate of the electrochemical reaction, which are homogeneously mixed and forms a stable and three-dimensional structure. Also, this homogeneously-structured catalyst/enzyme composite is applicable as a working electrode of the bioreceptor in a mini-biosensor.
Type:
Grant
Filed:
September 22, 2010
Date of Patent:
December 3, 2013
Assignee:
National Taiwan University of Science and Technology
Abstract: A substantially pure Candida host cell is provided for the biotransformation of a substrate to a product wherein the host cell is characterized by a first genetic modification class that comprises one or more genetic modifications that collectively or individually disrupt at least one alcohol dehydrogenase gene in the substantially pure Candida host cell.
Abstract: Disclosed is a polynucleotide encoding ?-butyrobetaine hydroxylate (?-BBH) originating from Neurospora crassa. Also disclosed are a recombinant vector comprising the polynucleotide, a transformant transformed with the recombinant vector, ?-BBH encoded by the polynucleotide, and a method of preparing L-carnitine, which comprises hydroxylating ?-butyrobetaine using ?-BBH encoded by the polynucleotide.
Type:
Grant
Filed:
February 25, 2005
Date of Patent:
December 3, 2013
Assignee:
CJ Cheiljedang Corporation
Inventors:
Sung Oh Chung, Bheonk-Uk Lee, Whan-Koo Kang, Jae Yeong Ju, Eun Sung Koh, Sung-Sik Park, Young-Hoon Park
Abstract: The invention pertains to the field of reaction systems generating malodour, particularly from constituents of human sweat. Specifically, the invention pertains to proteins for generating malodours, substrates for generating such malodour, inhibitors of such malodour generation and test and screening systems for measuring their malodour inhibition efficacy and finding substances previously not known to inhibit malodour generation. Thus, the invention also pertains to the field of deodorants.
Abstract: Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.
Type:
Application
Filed:
May 2, 2011
Publication date:
November 28, 2013
Applicants:
PANGU BIOPHARMA LIMITED, ATYR PHARMA, INC.
Inventors:
Leslie Ann Greene, Kyle P. Chiang, Fei Hong, Alain Philippe Vasserot, Jeffry D. Watkins, Cheryl L. Quinn, Wing-Sze Lo, John D. Mendlein
Abstract: The present invention relates to variant glucoamylases wherein the variant has altered properties (e.g., improved thermostability and/or specific activity) compared to a corresponding parent glucoamylase. The present invention also relates to enzyme compositions comprising a variant glucoamylase (e.g., starch hydrolyzing compositions); DNA constructs comprising polynucleotides encoding the variants and methods of producing the variant glucoamylases in host cells.
Type:
Grant
Filed:
April 8, 2008
Date of Patent:
November 26, 2013
Assignee:
Danisco US Inc.
Inventors:
Wolfgang Aehle, Richard R. Bott, Igor Nikolaev, Martijn Scheffers, Piet Van Solingen, Casper Vroemen
Abstract: Recombinant carrier molecules having amino acid sequences from thermostable enzymes and methods of use for expression, recovery and delivery of foreign sequences (peptides and polypeptides) produced in different systems (bacteria, yeast, DNA, cell cultures such as mammalian, plant, insect cell cultures, protoplast and whole plants in vitro or in vivo are provided. The recombinant carrier molecule using sequences from lichenase B (Lic B) were also made and used as part of carrier protein to express, recover and deliver a variety of target polypeptides of interest.
Type:
Grant
Filed:
April 12, 2012
Date of Patent:
November 26, 2013
Assignee:
iBio, Inc.
Inventors:
Vidadi Yusibov, Vadim Mett, Konstantin Musiychuk
Abstract: The present invention relates to an industrial process for the reduction of 4-androstene-3,17-dione in order to obtain testosterone using a particularly stable and selective enzyme produced in a recombinant manner.
Type:
Grant
Filed:
June 15, 2010
Date of Patent:
November 26, 2013
Assignee:
F.I.S. Fabbrica Italiana Sintetici S.p.A.
Abstract: The invention relates to Mutant cellobiohydrolase, being a mutant of SEQ ID NO:1, having a substitution at position N247(I,F,H,W) of SEQ ID NO: 1, wherein the mutant cellobiohydrolase has at least 50% sequence identity with SEQ ID NO: 1, and wherein the mutant cellobiohydrolase has CBHI activity.
Type:
Application
Filed:
January 30, 2012
Publication date:
November 21, 2013
Applicant:
DSM IP ASSETS B.V.
Inventors:
Jan Metske Van Der Laan, Margot Elisabeth Francoise Schooneveld-Bergmans, Denise Ilse Jacobs
Abstract: A method for fermenting a microorganism, producing a compound of interest, in a culture medium comprising: adding a browned glucose solution to the culture medium, wherein the browned glucose solution is a glucose solution that has been acid treated and heated to a temperature of at least 90 degrees Celsius, and wherein the glucose solution has a concentration of at least 500 g/l.
Abstract: The present invention provides a process and an apparatus for transferring a solute from a first fluid to a second fluid immiscible in each other.
Abstract: The invention concerns the production by microbiological process of oligopolysaccharides of biological interest. More particularly, the invention concerns a method for synthesizing in vivo the oligopolysaccharides by internalization of an exogenous precursor in growing bacterial cells expressing adequate modifying and glycosylating genes.
Type:
Grant
Filed:
October 31, 2007
Date of Patent:
November 19, 2013
Assignee:
Centre National de la Recherche Scientifique (CNRS)
Abstract: Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.
Type:
Grant
Filed:
May 27, 2009
Date of Patent:
November 19, 2013
Assignees:
3M Innovative Properties Company, Wisconsin Alumni Research Foundation
Inventors:
Mark R. Etzel, Yi He, Steven M. Heilmann, Jerald K. Rasmussen, Kannan Seshadri, Simon K. Shannon, Clinton P. Waller, Jr., Douglas E. Weiss
Abstract: The invention relates to the field of medicine and in particular to the use of alkaline phosphatase in the treatment of renal diseases, such as reduced renal function. The present invention also relates to the field of pharmacy and in particular to the pharmaceutical use of alkaline phosphatase. The present invention provides an alternative treatment to improve a situation in which the renal function is reduced by using alkaline phosphatase.
Type:
Grant
Filed:
January 30, 2008
Date of Patent:
November 19, 2013
Assignee:
AM-Pharma B.V.
Inventors:
Roelof P. Pickkers, Suzanne Heemskerk, Markwin P. Velders, Willem Raaben, Marty B. F. Wulferink
Abstract: The present invention relates to specially selected catalase enzymes and their use in reducing hydrogen peroxide in applications, and particularly in aseptic packaging applications.
Type:
Grant
Filed:
July 11, 2012
Date of Patent:
November 19, 2013
Assignee:
Ecolab USA Inc.
Inventors:
Brandon L. Herdt, Joshua P. Magnuson, David D. McSherry, Junzhong Li, Krista L. Owens
Abstract: In a method for producing a target substance utilizing a microorganism comprising culturing the microorganism in a medium to produce and cause accumulation of the target substance in the medium and collecting the target substance, there is used, as the microorganism, a mutant strain or a genetic recombinant strain constructed from a parent strain of the microorganism having a respiratory chain pathway of high energy efficiency and a respiratory chain pathway of low energy efficiency as respiratory chain pathways, and having either one or both of the following characteristics: (A) the respiratory chain pathway of high energy efficiency is enhanced, (B) the respiratory chain pathway of low energy efficiency is deficient.
Abstract: A two-stage heat treatment process is provided to improve the processability of recombinant microbial biomass comprising an enzyme having perhydrolytic activity. More specifically, a process is provided to treat the recombinant microbial biomass comprising a Thermotoga sp. acetyl xylan esterase having perhydrolytic activity such that microfiltration may be used to partially-purify and/or concentrate protein preparations. The acetyl xylan esterase may be used to produce peroxycarboxylic acids suitable for use in a variety of applications such as cleaning, disinfecting, sanitizing, bleaching, wood pulp processing, and paper pulp processing applications.
Type:
Grant
Filed:
March 23, 2011
Date of Patent:
November 19, 2013
Assignee:
E. I. du Pont de Nemours and Company
Inventors:
Robert Dicosimo, Arie Ben-Bassat, Raymond Richard Zolandz
Abstract: One aspect of the present invention relates to mesostructured zeolites. The invention also relates to a method of preparing mesostructured zeolites, as well as using them as cracking catalysts for organic compounds and degradation catalysts for polymers.
Abstract: The NonA alkene synthase in Synechococcus sp. displays selective synthesis of 1-nonadecene. Heterologous recombination of a domain, i.e. the acyl binding domain, with other acyl binding proteins, affects acyl substrate chain-length binding selectivity and therefore the chain-length of the synthesized 1-alkenes. Compositions and methods are provided to selectively synthesize 1-alkenes of various chain lengths.
Abstract: The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) which have an increased substrate specificity compared with the wild type, and also to methods for production and identification thereof.
Type:
Grant
Filed:
June 17, 2009
Date of Patent:
November 12, 2013
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Walter Weichel, Volker Möhrle, Markus Schindler, Rainhard Koch, Rolandas Meskys
Abstract: Methods for demannosylating phosphorylated N-glycans on a glycoprotein are described that use a mannosidase capable of hydrolyzing a terminal alpha-1,2 mannose linkage when the underlying mannose is phosphorylated.
Type:
Application
Filed:
September 29, 2011
Publication date:
November 7, 2013
Applicant:
OXYRANE UK LIMITED
Inventors:
Kathleen Camilla Telesphore Alida Maria Piens, Wouter Vervecken
Abstract: The present invention relates to a modified polypeptide with a biological activity to lyse cell walls of bacteria, wherein the polypeptide has no caspase, clostripain, enterokinase, factor Xa, granzyme B, staphylococcus peptidase I (V8 Protease), plasmin, streptopain, bacillolysin and/or thrombin cleavage site. The invention further relates to nucleic acids with a sequence encoding a polypeptide according to the present invention.